Search This Blog

Monday, June 24, 2019

NGM started at Buy by Stifel

Analyst Derek Archila initiates coverage on NGM Biopharmaceuticals (NASDAQ: NGM) with a Buy

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)